• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型Y RNA衍生片段可区分犬肝细胞癌与肝细胞腺瘤。

Novel Y RNA-Derived Fragments Can Differentiate Canine Hepatocellular Carcinoma from Hepatocellular Adenoma.

作者信息

Ushio Norio, Hasan Md Nazmul, Arif Mohammad, Miura Naoki

机构信息

United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-0841, Japan.

Joint Graduate School of Veterinary Medicine, Kagoshima University, 1-21-24 Korimoto, Kagoshima 890-0065, Japan.

出版信息

Animals (Basel). 2023 Sep 28;13(19):3054. doi: 10.3390/ani13193054.

DOI:10.3390/ani13193054
PMID:37835660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10571523/
Abstract

Hepatocellular carcinomas (HCC) are common tumors, whereas hepatocellular adenomas (HCA) are rare, benign tumors in dogs. The aberrant expression of noncoding RNAs (ncRNAs) plays a pivotal role in HCC tumorigenesis and progression. Among ncRNAs, micro RNAs have been widely researched in human HCC, but much less widely in canine HCC. However, Y RNA-derived fragments have yet to be investigated in canine HCC and HCA. This study targeted canine HCC and HCA patients. We used qRT-PCR to determine Y RNA expression in clinical tissues, plasma, and plasma extracellular vesicles, and two HCC cell lines (95-1044 and AZACH). Y RNA was significantly decreased in tissue, plasma, and plasma extracellular vesicles for canine HCC versus canine HCA and healthy controls. Y RNA was decreased in 95-1044 and AZACH cells versus normal liver tissue and in AZACH versus 95-1044 cells. In plasma samples, Y RNA levels were decreased in HCC versus HCA and Healthy controls and increased in HCA versus Healthy controls. Receiver operating characteristic analysis showed that Y RNA could be a promising biomarker for distinguishing HCC from HCA and healthy controls. Overall, the dysregulated expression of Y RNA can distinguish canine HCC from HCA. However, further research is necessary to elucidate the underlying Y RNA-related molecular mechanisms in hepatocellular neoplastic diseases. To the best of our knowledge, this is the first report on the relative expression of Y RNA in canine HCC and HCA.

摘要

肝细胞癌(HCC)是常见肿瘤,而肝细胞腺瘤(HCA)在犬类中是罕见的良性肿瘤。非编码RNA(ncRNA)的异常表达在HCC的肿瘤发生和进展中起关键作用。在ncRNA中,微小RNA在人类HCC中已得到广泛研究,但在犬类HCC中的研究较少。然而,Y RNA衍生片段在犬类HCC和HCA中尚未得到研究。本研究以犬类HCC和HCA患者为对象。我们使用qRT-PCR来确定临床组织、血浆和血浆细胞外囊泡以及两种HCC细胞系(95-1044和AZACH)中Y RNA的表达。与犬类HCA和健康对照相比,犬类HCC的组织、血浆和血浆细胞外囊泡中的Y RNA显著降低。与正常肝组织相比,95-1044和AZACH细胞中的Y RNA降低,与95-1044细胞相比,AZACH细胞中的Y RNA降低。在血浆样本中,与HCA和健康对照相比,HCC中的Y RNA水平降低,与健康对照相比,HCA中的Y RNA水平升高。受试者工作特征分析表明,Y RNA可能是区分HCC与HCA和健康对照的有前景的生物标志物。总体而言,Y RNA的表达失调可区分犬类HCC与HCA。然而,有必要进一步研究以阐明肝细胞肿瘤性疾病中与Y RNA相关的潜在分子机制。据我们所知,这是关于Y RNA在犬类HCC和HCA中相对表达的首次报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/ad3be5ead595/animals-13-03054-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/13dd925adb25/animals-13-03054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/9a149ac80b2f/animals-13-03054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/05978b2d0b96/animals-13-03054-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/33593b48953a/animals-13-03054-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/ad3be5ead595/animals-13-03054-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/13dd925adb25/animals-13-03054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/9a149ac80b2f/animals-13-03054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/05978b2d0b96/animals-13-03054-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/33593b48953a/animals-13-03054-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b894/10571523/ad3be5ead595/animals-13-03054-g005.jpg

相似文献

1
Novel Y RNA-Derived Fragments Can Differentiate Canine Hepatocellular Carcinoma from Hepatocellular Adenoma.新型Y RNA衍生片段可区分犬肝细胞癌与肝细胞腺瘤。
Animals (Basel). 2023 Sep 28;13(19):3054. doi: 10.3390/ani13193054.
2
Aberrantly Expressed tRNA-Val Fragments Can Distinguish Canine Hepatocellular Carcinoma from Canine Hepatocellular Adenoma.异常表达的 tRNA-Val 片段可区分犬肝细胞癌与犬肝细胞腺瘤。
Genes (Basel). 2024 Aug 4;15(8):1024. doi: 10.3390/genes15081024.
3
YRNA and tRNA fragments can differentiate benign from malignant canine mammary gland tumors.YRNA 和 tRNA 片段可区分良、恶性犬乳腺肿瘤。
Biochem Biophys Res Commun. 2024 Jan 8;691:149336. doi: 10.1016/j.bbrc.2023.149336. Epub 2023 Nov 28.
4
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.利用 microRNA 谱分析和靶向基因测序对肝细胞腺瘤和癌进行特征分析。
PLoS One. 2018 Jul 27;13(7):e0200776. doi: 10.1371/journal.pone.0200776. eCollection 2018.
5
Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features.交界性肝细胞腺瘤:基于病理和分子特征的实用诊断方法。
Mod Pathol. 2023 Sep;36(9):100211. doi: 10.1016/j.modpat.2023.100211. Epub 2023 May 9.
6
Whole-exome sequencing-based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma.基于全外显子组测序的肝细胞腺瘤恶性转化为肝细胞癌的突变特征分析。
Clin Exp Pharmacol Physiol. 2024 Jul;51(7):e13901. doi: 10.1111/1440-1681.13901.
7
Dynamic Contrast Enhanced-MRI and Apparent Diffusion Coefficient Quantitation for Differentiate Hepatocellular Carcinoma from Hepatocellular Adenoma.动态对比增强磁共振成像和表观扩散系数定量在肝细胞癌与肝细胞腺瘤鉴别诊断中的应用。
Asian Pac J Cancer Prev. 2024 Mar 1;25(3):931-937. doi: 10.31557/APJCP.2024.25.3.931.
8
Phospholipase A2 Group IIA Is Associated with Inflammatory Hepatocellular Adenoma.磷脂酶A2第二亚组A与炎性肝细胞腺瘤相关。
Cancers (Basel). 2023 Dec 28;16(1):159. doi: 10.3390/cancers16010159.
9
Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.伴有微小恶性转化灶的肝细胞腺瘤或恶性腺瘤切除术后的长期预后。
JHEP Rep. 2021 Jun 29;3(4):100326. doi: 10.1016/j.jhepr.2021.100326. eCollection 2021 Aug.
10
Hypoxia-related Y RNA fragments as a novel potential biomarker for distinguishing metastatic oral melanoma from non-metastatic oral melanoma in dogs.缺氧相关 Y RNA 片段作为一种新型潜在生物标志物,用于区分犬口腔转移性黑色素瘤与非转移性口腔黑色素瘤。
Vet Q. 2024 Dec;44(1):1-8. doi: 10.1080/01652176.2023.2300943. Epub 2024 Jan 30.

本文引用的文献

1
YRNA and tRNA fragments can differentiate benign from malignant canine mammary gland tumors.YRNA 和 tRNA 片段可区分良、恶性犬乳腺肿瘤。
Biochem Biophys Res Commun. 2024 Jan 8;691:149336. doi: 10.1016/j.bbrc.2023.149336. Epub 2023 Nov 28.
2
Needle tract seeding and malignant transformation of hepatocellular adenoma into well-differentiated hepatocellular carcinoma in a dog.犬肝细胞腺瘤针道种植及向高分化肝细胞癌的恶性转化
Vet Clin Pathol. 2023 Sep;52(3):507-513. doi: 10.1111/vcp.13221. Epub 2023 May 18.
3
Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study.
犬肾上腺皮质功能亢进相关肝细胞癌的血清类固醇谱分析:一项初步研究。
Front Vet Sci. 2022 Sep 28;9:1014792. doi: 10.3389/fvets.2022.1014792. eCollection 2022.
4
Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.微小 RNA 的参与及其在肝细胞癌中的潜在诊断、治疗和预后作用。
J Clin Lab Anal. 2022 Oct;36(10):e24673. doi: 10.1002/jcla.24673. Epub 2022 Aug 29.
5
Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.甲基化 YBX1 介导的 hY4 RNA 片段的选择性分选和分泌到细胞外囊泡中促进肺癌进展。
J Exp Clin Cancer Res. 2022 Apr 11;41(1):136. doi: 10.1186/s13046-022-02346-w.
6
Long non-coding RNA and transfer RNA-derived small fragments in exosomes are potential biomarkers for canine oral melanoma.外泌体中的长非编码 RNA 和转移 RNA 衍生的小片段是犬口腔黑色素瘤的潜在生物标志物。
Vet Comp Oncol. 2022 Sep;20(3):653-663. doi: 10.1111/vco.12818. Epub 2022 Apr 17.
7
The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.肝细胞癌中 ncRNA 失调模式及其肿瘤微环境的作用机制。
Front Immunol. 2022 Feb 23;13:847728. doi: 10.3389/fimmu.2022.847728. eCollection 2022.
8
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients.潜在的血浆生物标志物:miRNA-29c、miRNA-21 和 miRNA-155 在肝癌患者的临床进展中的作用。
PLoS One. 2022 Feb 14;17(2):e0263298. doi: 10.1371/journal.pone.0263298. eCollection 2022.
9
Identification of melanoma-specific exosomal miRNAs as the potential biomarker for canine oral melanoma.鉴定黑色素瘤特异性外泌体 miRNA 作为犬口腔黑色素瘤的潜在生物标志物。
Pigment Cell Melanoma Res. 2021 Nov;34(6):1062-1073. doi: 10.1111/pcmr.13000. Epub 2021 Aug 2.
10
The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.细胞外囊泡在肝细胞癌疾病进展及检测中的作用
Cancers (Basel). 2021 Jun 20;13(12):3076. doi: 10.3390/cancers13123076.